Copyright
©The Author(s) 2017.
World J Gastroenterol. Mar 7, 2017; 23(9): 1594-1601
Published online Mar 7, 2017. doi: 10.3748/wjg.v23.i9.1594
Published online Mar 7, 2017. doi: 10.3748/wjg.v23.i9.1594
Figure 2 miR-1181 inhibited pancreatic cancer cell migration and invasion.
A: Indicated PANC-1 cells were subjected to transwell assays and relative migration and invasion capability was quantitative analyzed (B and C), aP < 0.05; D: Indicated MIA-PaCa-2 cells were subjected to transwell assays and relative migration and invasion capability was quantitative analyzed (E and F), aP < 0.05; G and I: Indicated PANC-1 and MIA-PaCa-2 (H and J) cells were subjected to wound-healing assays and quantitative analyzed, aP < 0.05, bP < 0.01, eP < 0.001; K: Immunofluorescence staining shows decreased F-actin and β-tubulin expression in PANC-1 cells over-expressing miR-1181 compared with the blank control and negative control (NC) cells.
- Citation: Wang J, Guo XJ, Ding YM, Jiang JX. miR-1181 inhibits invasion and proliferation via STAT3 in pancreatic cancer. World J Gastroenterol 2017; 23(9): 1594-1601
- URL: https://www.wjgnet.com/1007-9327/full/v23/i9/1594.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i9.1594